Hong Kong vs United Arab Emirates: HIV-positive TB patients on ART (antiretroviral therapy)
Hong Kong
100.0%
in 2024
United Arab Emirates
100.0%
in 2024
Hong Kong rank
1st
United Arab Emirates rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Hong Kong
- United Arab Emirates
How they compare
Hong Kong currently reports 100.0% against 100.0% in United Arab Emirates, a difference of 0.0%.
Across all 10 years both countries report, United Arab Emirates has been ahead every year.
Hong Kong ranks 1st and United Arab Emirates ranks 1st of 144 countries.
United Arab Emirates has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Hong Kong | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29.1% | 100.0% | 70.9% | United Arab Emirates |
| 2020s | 92.2% | 100.0% | 7.8% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Hong Kong or United Arab Emirates?
- Hong Kong, at 100.0% against 100.0% in United Arab Emirates as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Hong Kong and United Arab Emirates?
- 0.0%, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and United Arab Emirates?
- 10 years are reported by both, from 2010 to 2024.
- How do Hong Kong and United Arab Emirates rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Hong Kong ranks 1st and United Arab Emirates ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.